IL6 and systemic inflammatory response syndrome: Follow-up of survivors at six and twelve months post-discharge, including evaluation of cognitive function, quality of life, and functional status, could determine whether admission biomarker profiles, particularly IL-6 levels, predict the risk of developing post-sepsis syndrome.